The latest plan by 23andMe co-founder and CEO Anne Wojcicki to acquire the genetic testing company was rejected by a special ...
Ms. Wojcicki’s proposal, which was included in an amended Schedule 13D filing made by Ms. Wojcicki with the Securities and ...
Me’s special committee of independent directors on Monday rejected CEO Anne Wojcicki’s proposal to take the distressed ...
The special committee of the board of directors of 23andMe (ME) confirmed receipt of a non-binding proposal from Anne Wojcicki, CEO, ...
which was included in an amended Schedule 13D filing made by Ms. Wojcicki with the Securities and Exchange Commission earlier today, represented an 84% decrease to the $2.53 per share price ...
The latest plan by 23andMe co-founder and CEO Anne Wojcicki to acquire ... But this one comes with a twist: Wojcicki said in a Securities and Exchange Commission filing that New Mountain Capital ...
March 03, 2025 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. ("23andMe” or the "Company”) (Nasdaq: ME) today confirmed receipt of a non-binding proposal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results